Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

NCT02727101 ·Status: TERMINATED ·Phase: PHASE4

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00735397 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00699972 ·Status: COMPLETED ·Phase: PHASE3

A Study of Intravenous Perampanel in Japanese Participants With Epilepsy

NCT03754582 ·Status: COMPLETED ·Phase: PHASE2

A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures

NCT04257604 ·Status: COMPLETED

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

NCT01527006 ·Status: COMPLETED ·Phase: PHASE2

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

NCT01393743 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

NCT04015141 ·Status: RECRUITING ·Phase: PHASE2

To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00699582 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

NCT05684978 ·Status: TERMINATED ·Phase: PHASE4

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

NCT01161524 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

NCT00866775 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00700310 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

NCT05533814 ·Status: COMPLETED ·Phase: PHASE4

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

NCT00368472 ·Status: COMPLETED ·Phase: PHASE2

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

NCT00903786 ·Status: COMPLETED ·Phase: PHASE2

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

NCT06453213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years

NCT02033902 ·Status: COMPLETED

A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older

NCT03836924 ·Status: COMPLETED

Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

NCT02849626 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy

NCT02914314 ·Status: COMPLETED ·Phase: PHASE2

Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy

NCT05497193 ·Status: UNKNOWN

A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures

NCT04202159 ·Status: COMPLETED

A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy

NCT04230044 ·Status: COMPLETED

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

NCT02220972 ·Status: WITHDRAWN ·Phase: PHASE4